BRTX (STOCKS)
BioRestorative Therapies, Inc. Common Stock (NV)
$0.410000
+0.057500 (+16.31%)
Prev close: $0.352500
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Lance Alstodt
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10.30M
- Employees
- 11
- P/E (TTM)
- -0.35
- P/B (TTM)
- 2.97
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.12 | $-0.20 | +0.0840 | +41.18% |
|
Dec 2025 (Q4)
|
$-0.31 | $-0.38 | +0.0674 | +17.86% |
|
Sep 2025 (Q3)
|
$-0.33 | $-0.37 | +0.0372 | +10.13% |
|
Jun 2025 (Q2)
|
$-0.30 | $-0.39 | +0.0876 | +22.60% |
Financial Statements
| Revenues | $357.87K |
| Benefits Costs and Expenses | $14.56M |
| Cost Of Revenue | $28.32K |
| Costs And Expenses | $13.14M |
| Gross Profit | $329.55K |
| Nonoperating Income/Loss | $3.17M |
| Operating Expenses | $14.55M |
| Depreciation and Amortization | $210.60K |
| Research and Development | $9.37M |
| Other Operating Expenses | $5.08M |
| Operating Income/Loss | -$14.23M |
| Income/Loss From Continuing Operations After Tax | -$11.02M |
| Income/Loss From Continuing Operations Before Tax | -$17.16M |
| Interest And Dividend Income, Operating | $173.84K |
| Net Income/Loss | -$11.06M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.06M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.06M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.07 |
| Diluted Earnings Per Share | -$1.07 |
| Basic Average Shares | 35,835,331 |
| Diluted Average Shares | 35,835,331 |
| Assets | $4.64M |
| Current Assets | $3.80M |
| Noncurrent Assets | $840.57K |
| Fixed Assets | $328.81K |
| Intangible Assets | $511.76K |
| Liabilities | $1.61M |
| Current Liabilities | $1.61M |
| Accounts Payable | $666.90K |
| Wages | $746.00K |
| Other Current Liabilities | $201.74K |
| Noncurrent Liabilities | $0.00 |
| Equity | $3.03M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.03M |
| Liabilities And Equity | $4.64M |
| Net Cash Flow From Operating Activities | -$11.82M |
| Net Cash Flow From Operating Activities, Continuing | -$11.82M |
| Net Cash Flow From Investing Activities | $7.50M |
| Net Cash Flow From Investing Activities, Continuing | $7.50M |
| Net Cash Flow From Financing Activities | $6.20M |
| Net Cash Flow From Financing Activities, Continuing | $6.20M |
| Net Cash Flow | $1.88M |
| Net Cash Flow, Continuing | $1.88M |
| Comprehensive Income/Loss | -$11.06M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.06M |
| Other Comprehensive Income/Loss | $0.00 |